Based on the data from TCGA and GTEx databases, WDR62 expression was analyzed at the pan-cancer level using the Sangerbox web tool, and the results showed that WDR62 was highly expressed in the majority of tumor types (Fig. 2A), suggesting that WDR62 functions as a broad-spectrum oncogene associated with a variety of human tumors. This evidence concerns the gene WDR62 and cancer.